Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas

NCT00978458 is registered in ClinicalTrials.gov with Eastern Cooperative Oncology Group as lead sponsor.

NCT NCT00978458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00978458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Radiation Therapy With or Without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas
Lead sponsor
Eastern Cooperative Oncology Group
Phase
Phase 3
Overall status
Active, not recruiting
Start date
November 17, 2009
Completion date
December 31, 2026
Enrollment
540 (actual)
Sites
168

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, neurotoxicity